HK-based buyout firm Baring to invest $100m in Chinese drug maker Hutchmed

Retrieved on: 2021-04-09 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

HK-based buyout firm Baring to invest $100m in Chinese drug maker Hutchmed. View article details on hiswai:

Excerpt

Hong Kong-based buyout firm Baring Private Equity Asia has agreed to purchase $100 million worth of shares in Hutchison China MediTech ...

Article found on: www.dealstreetasia.com